Rebuttal of: "Can home prophylaxis for venous thromboembolism reduce mortality rates in patients with chronic obstructive pulmonary disease?" [2];A propósito de: "¿Puede reducir la mortalidad de los pacientes con EPOC la profilaxis domiciliaria de la enfermedad tromboembólica venosa?"

Archivos de Bronconeumologia

Volumn 43, Issue 9, 2007, Pages 523-524

  Rocha, Eduardo ^a   Jiménez, David ^b  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACCELEROMETER; ADULT; AGED; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; DAILY LIFE ACTIVITY; FEMALE; HOME CARE; HOSPITAL ADMISSION; HUMAN; LETTER; MALE; MORTALITY; PHYSICAL ACTIVITY; PROPHYLAXIS; REPRODUCIBILITY; SOCIOECONOMICS; VENOUS THROMBOEMBOLISM;

EID: 36049044481     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1157/13109475     Document Type: Letter

References (6)

1. Modesto-Alapont M, Nauffal-Manzur D, Ansotegui-Barrera E, Menéndez-Villanueva R, Ballesta A, Touza R, et al. ¿Puede reducir la mortalidad de los pacientes con EPOC la profilaxis domiciliaria de la enfermedad tromboembólica venosa? Arch Bronconeumol. 2006;42:130-4.
2. Samama MM, Cohen AT, Darmon JY, Desjardins L, Eldor A, Janbon C, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med. 1999;341:793-800.
3. Lindblad B, Sternby NH, Bergqvist D. Incidence of venous thromboembolism verified by necropsy over 30 years. BMJ. 1991;302:709-11.
4. McKelvie PA. Autopsy evidence of pulmonary thromboembolism. Med J Aust. 1994;160:127-8.
5. Suchankova J, Mata M, Cortijo J, Morcillo EJ. Effects of bemiparin on airway responses to antigen in sensitized Brown-Norway rats. Eur J Pharmacol. 2005;507:261-71.
6. European Medicines Agency (EMEA). Committee for Medicinal Products for Human Use (CHMP). Guideline on clinical investigation of medicinal products for the prophylaxis of venous thromboembolic risk in non-surgical patients. Doc. Ref. CPMP/EWP/6235/04. London: EMEA; June 2006.